Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001415889-25-021902
Filing Date
2025-08-14
Accepted
2025-08-14 16:42:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 16387
  Complete submission text file 0001415889-25-021902.txt   18134
Mailing Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932 646-528-4184
BeyondSpring Inc. (Subject) CIK: 0001677940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90237 | Film No.: 251220294
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address PO BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address PO BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 345-949-8066
Decheng Capital Management III (Cayman), LLC (Filed by) CIK: 0001747821 (see all company filings)

EIN.: 981423513 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A